Some inhibitors of RTKs/PI3K/AKT/mTOR increase the sensitivity of apoptosis-resistant glioblastoma cells to pro-apoptotic and/or pro-autophagic drugs (Figure 8). The gene discussed is AKT1; the disease is glioblastoma.